Moderna · Multi-Quarter Financial Trends

16 quarters · As reported by the company · Amounts in USD billions← MRNA

Quarter	Period End	Revenue ($B)	YoY	Gross Margin	Operating Income ($B)	Net Income ($B)	Net Margin	Free Cash Flow ($B)	EPS	Buybacks ($B)	Dividends ($B)
FY2026 Q2	2026-06-30	0.15	+2.1%	35.9%	-0.82	-0.78	-539.3%	-0.56	-1.97	—	—
FY2026 Q1	2026-03-31	0.39	+260.2%	-145.5%	-1.39	-1.34	-345.2%	-0.69	-3.40	—	—
FY2025 Q4	2025-12-31	0.68	−29.8%	33.3%	-0.86	-0.83	-121.8%	0.89	-2.10	—	—
FY2025 Q3	2025-09-30	1.02	−45.4%	79.6%	-0.26	-0.20	-19.7%	-0.88	-0.51	—	—
FY2025 Q2	2025-06-30	0.14	−41.1%	16.2%	-0.91	-0.83	-581.0%	-0.92	-2.13	—	—
FY2025 Q1	2025-03-31	0.11	−35.3%	16.7%	-1.05	-0.97	-899.1%	-1.15	-2.52	—	—
FY2024 Q4	2024-12-31	0.97	−65.6%	23.5%	-1.25	-1.12	-115.9%	0.30	-2.91	0.00	—
FY2024 Q3	2024-09-30	1.86	+1.7%	72.4%	-0.07	0.01	0.7%	-1.72	0.03	0.00	—
FY2024 Q2	2024-06-30	0.24	−29.9%	52.3%	-1.36	-1.28	-530.7%	-1.46	-3.33	0.00	—
FY2024 Q1	2024-03-31	0.17	−91.0%	42.5%	-1.27	-1.18	-703.6%	-1.19	-3.07	0.00	—
FY2023 Q4	2023-12-31	2.81	−44.7%	67.0%	0.01	0.22	7.7%	0.40	0.63	0.00	—
FY2023 Q3	2023-09-30	1.83	−45.6%	-22.4%	-2.01	-3.63	-198.3%	-1.74	-9.53	-0.00	—
FY2023 Q2	2023-06-30	0.34	—	-112.5%	-1.87	-1.38	-401.2%	-1.15	-3.62	0.63	—
FY2023 Q1	2023-03-31	1.86	—	57.5%	-0.37	0.08	4.2%	-1.34	0.19	0.53	—
FY2022 Q4	2022-12-31	5.08	—	62.3%	1.58	1.47	28.8%	1.57	3.77	0.40	—
FY2022 Q3	2022-09-30	3.36	—	67.3%	1.17	1.04	31.0%	0.16	2.53	1.01	—

Quarterly figures come from the company's 10-Q and 10-K filings. The fourth quarter is derived as the full year minus the first three quarters; cash flow items are converted from fiscal year-to-date totals into single quarters.